Kumudu Pathiraja

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.

Lajos Pusztai, Rita Nanda, L. Pusztai, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.